HEALWELL achieved quarterly revenue from continuing operations of $14.1 million in Q1-2025, 208% higher than the $4.6 million generated in Q1-2024. Revenue growth was driven by acquisitions in the past year and record growth of 224% in the Company's AI and Data Science business. On April 1, 2025, HEALWELL completed the acquisition of Orion Health, which is expected to contribute approximately $100 million in annual SaaS and... Read More

HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, May 13, 2025, at 1:00 pm ET (10:00 am PT). Toronto, Ontario--(Newsfile Corp. - May 6, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2025 financial results for the... Read More

Toronto, Ontario--(Newsfile Corp. - April 23, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare artificial intelligence company focused on preventative care, today announces a number of key executive appointments to the Company's senior leadership team to reflect HEALWELL's focus on building a high-impact leadership team to guide the Company as it shifts to its next phase of... Read More

HEALWELL has acquired Auckland, New Zealand-based Orion Health Holdings Limited ("Orion Health"), a global healthcare intelligence platform providing subscription licenses and services to marquee public sector clients with data interoperability and healthcare navigation products. Orion Health 1 has approximately 400 employees with offices in 11 countries globally. Its software solutions currently support over 70 public and... Read More

Toronto, Ontario--(Newsfile Corp. - March 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare artificial intelligence company focused on preventative care, announced today that it understands WELL Health Technologies Corp. (" WELL ") intends to exercise its right to acquire 30,800,000 Class A Subordinate Voting Shares (" SVS ") and 30,800,000 Class B Multiple Voting Shares... Read More

Correction from Source: In the previously issued press release this morning, the full year 2024 Adjusted EBITDA loss was inadvertently reported as $1 million. The correct Adjusted EBITDA (1) loss is $16 million. The press release is re-issued below in its entirety with this one correction. HEALWELL achieved record annual revenue from continuing operations of approximately $39 million in fiscal 2024, an increase of 433%... Read More

HEALWELL achieved record annual revenue from continuing operations of approximately $39 million in fiscal 2024, an increase of 433% compared to fiscal 2023. HEALWELL achieved record quarterly revenue from continuing operations of $15.2 million in Q4-2024, 692% higher than the $1.9 million generated in Q4-2023 and 11% higher than the $13.7 million generated in Q3-2024. On December 16, 2024, HEALWELL announced the acquisition... Read More

HEALWELL AI to hold a conference call and simultaneous webcast on Wednesday, March 26, 2025, at 1:00 pm ET (10:00 am PT). Toronto, Ontario--(Newsfile Corp. - March 20, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2024... Read More

HEALWELL has signed a $50 million credit agreement, contingent on and in support of its acquisition of Orion Health, with credit to be provided by a syndicate of Schedule I Canadian Banks, including The Bank of Nova Scotia as Sole Bookrunner, Admin Agent, and Co-Lead Arranger, and Royal Bank of Canada as Co-lead Arranger. The credit agreement also provides for an additional uncommitted future accordion feature of up to $25... Read More

28th Annual Scotiabank TMT Conference on March 4-5, 2025, in Toronto, ON 37th Annual ROTH Conference on March 16-18, 2025, in Dana Point, CA Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - HEALWELL AI Inc . (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL AI,... Read More

VeroSource to support cutting edge Digital Twin technology on its VS Data-as-a-Service Platform, delivering real-time insights and advanced data visualization to optimize healthcare operations. A Digital Twin is a virtual model of a healthcare system or facility that provides real-time insights for better decision-making. By simulating operations without disruption, this technology allows healthcare managers to optimize... Read More

In Q4-2024, HEALWELL's subsidiary, Khure Health ("Khure") helped physicians identify over 43,000 high-risk patients with its AI-Powered Physician Co-Pilots, across 8 clinical specialities harnessing 132 disease specific algorithms. This figure reflected a quarter over quarter sequential growth of 22% as compared to Q3-2024 and year-over-year growth of 500% as compared to Q4-2023. HEALWELL has executed 4 new Master Services... Read More

The use of the DARWEN™ AI platform achieved time savings representing a 100-fold improvement as compared to traditional manual processes (1) , demonstrating the opportunity to advance care and improve patient outcomes by leveraging cutting edge AI technology in clinical care. This study was conducted in collaboration with Princess Margaret Cancer Centre and is one of the world's first peer-reviewed studies to use an... Read More

HEALWELL receives consent from the Overseas Investment Office of New Zealand (the "OIO") for HEALWELL to acquire all of the shares (the "Orion Shares") of Orion Health Holdings Limited ("Orion Health"), as contemplated in the previously disclosed share purchase agreement dated December 16, 2024. Orion Health is a leader in global healthcare technology, with over 70 customers worldwide in 11 countries and approximately 400... Read More

HEALWELL expects to achieve at least $3.0 million in annual cost savings through a strategic cost optimization initiative. HEALWELL is focussed on aligning its operations ahead of the anticipated closing of its previously announced acquisition of New Zealand based Orion Health ("Orion") to optimize synergies and streamline operations between the two companies. HEALWELL also disclosed that it expects to be favourably... Read More

HEALWELL has completed the convertible debt tranche of its previously announced upsized $55 million bought deal financing, issuing subscription receipts for $30 million in convertible debentures. The proceeds of the financing, together with the $25.5 million equity tranche of the offering completed last week, will be used to fund the previously announced acquisition of New Zealand based Orion Health. Toronto,... Read More

HEALWELL has completed the equity tranche of its previously announced upsized $55 million bought deal financing, raising gross proceeds of $25.5M. The proceeds of the financing will be used to fund the previously announced acquisition of New Zealand based Orion Health. The balance of the bought deal financing consists of the convertible debenture portion of the offering, which the Company is now targeting to complete on or... Read More

The Company has obtained shareholder approval for its proposed acquisition of Orion Health and its previously announced $55 million bought-deal financing. The Company also announced that a Schedule A Bank has obtained internal risk approval for a senior secured credit facility in the amount of $50 million, subject to the Company finalizing a credit agreement with the Bank. The Company expects to complete its upsized bought... Read More

TORONTO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) (OTCQX:HWAIF), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an amended agreement pursuant to which Eight Capital and Scotiabank, as lead underwriters and joint bookrunners, together with a syndicate of underwriters (collectively, the “ Underwriters ”), will... Read More

HEALWELL AI has entered into an agreement to acquire 100% of the shares of Auckland, New Zealand based Orion Health Holdings Limited (“Orion Health”), a subscription license and services revenue business serving marquee public sector clients globally with data interoperability and healthcare navigation products and services. The two organisations are perfectly aligned on a combined mission to revolutionize healthcare through... Read More

HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using natural language processing and... Read More

More than 600,000 New Brunswick residents are now eligible to generate a Patient Summary on the VeroSource-built MyHealthNB digital front door. This year, MyHealthNB averaged over 35,000 unique monthly users in New Brunswick, reflecting 100% growth compared to 2023. The VeroSource-managed Saskatchewan Health Authority website was accessed by patients and providers over 1.3 million times in 2024, representing a 50% increase... Read More

HEALWELL AI announces the formation of a Strategic Advisory Board, designed to empower the Company's global growth initiatives and offer expert guidance on product development, ethical considerations related to use of AI, regulatory compliance, and market positioning. Beatrice York, Dr. Marcel Reichart and Reeva Misra have joined HEALWELL's Strategic Advisory Board, bringing expertise across international business, AI,... Read More

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN -- Roth Capital Partners, LLC (“ROTH”), www.roth.com , is pleased to announce it will host the 13th Annual Roth Technology Conference on November 19-20, 2024, at the Hard Rock Hotel, 159 W 48 th St, New York, NY 10036. The conference will provide pre-qualified institutional investors with the opportunity to network directly with C-level executives from approximately 120... Read More

HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024. Quarterly revenues were driven by HEALWELL completing the acquisitions of BioPharma Services Inc. and VeroSource Solutions Inc. during Q3-2024. Management maintains a positive outlook and based on current M&A... Read More

The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize. Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients and for using various... Read More

HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical companies in the world. HEALWELL's AI and data science subsidiaries generated patient identification revenue from 23 of these pharmaceutical partners in Q3-2024.... Read More

HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, November 12, 2024, at 1:00 pm EST (10:00 am PST). Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the Company will release its Fiscal Third Quarter 2024... Read More

WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging HEALWELL's Contract Research Organization (CRO) capabilities alongside WELL Health's network of clinics across Canada, positions the partnership as a formidable player in AI-driven clinical trials, and opens up new... Read More

HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology. Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that provides HEALWELL with exclusive distribution rights to the Canadian outpatient healthcare market. Abstractive Health's... Read More

Participating in-person at the LD Micro Main Event XVII from October 28-30 th at the Luxe Sunset Boulevard Hotel in Los Angeles Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL, will be... Read More

HEALWELL AI CEO, Dr. Alexander Dobranowski, to present live at 10:00 AM PT on Wednesday, October 9, 2024 Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9,... Read More

HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility. This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the... Read More

Pentavere is nominated for a 2024 Prix Galien Award for its contributions in AI and data science benefiting the human condition. The award is offered by the Galien Foundation and considered the most prestigious of all honours in the life sciences and pharmaceutical industry which is regularly awarded to recipients who are believed to have had the greatest impact on human health. This is Pentavere AI's third Prix Galien... Read More

WELL Health subsidiary, OceanMD, and HEALWELL subsidiary, Intrahealth, announce a partnership to integrate OceanMD's leading eReferral system across Intrahealth's global network to enhance digital interoperability, streamline healthcare processes, and improve patient access to care. This collaboration enables HEALWELL's Intrahealth to make OceanMD's eReferral system, which currently supports 120,000 eReferrals and eConsults... Read More

HEALWELL achieved record quarterly revenue from continuing operations of $5.44 million in Q2-2024, 205% higher than the $1.78 million generated in Q2-2023 and 19% higher than the $4.58 million generated in Q1-2024. HEALWELL also reported net income of $2.54 million as compared to a loss of $9.81 million in Q2 2023. This was primarily due to the successful removal and settling of a significant number of liabilities incurred... Read More

HEALWELL AI to hold a conference call and simultaneous webcast on Monday, August 12, 2024, at 5:30 pm EST (2:30 pm PST). Toronto, Ontario--(Newsfile Corp. - August 7, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2024 financial results for the period... Read More

HEALWELL's subsidiary, Intrahealth, announces a $9 million partnership with the New Zealand Department of Corrections over a 7-year agreement to improve offender healthcare through the delivery of a new patient management system. Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare technology company focused on AI and data science for... Read More

VeroSource, a subsidiary of HEALWELL, built the new Patient Summary feature that launched on the MyHealthNB mobile app in partnership with Canada Health Infoway and the Government of New Brunswick. The Patient Summary feature allows users to create a summary of their medical information including medications, immunizations, lab results and imaging reports, which can then be securely shared with healthcare professionals and... Read More

HEALWELL's current goal is to achieve run rate revenues approaching $100 million by the end of the year from today's current run rate of over $65 million. This goal is underpinned by a robust M&A pipeline where there are several advanced subjects including one signed LOI and helps the Company position itself to achieve profitability on an Adjusted EBITDA basis in 2025. HEALWELL's four acquisitions to date have positioned the... Read More

WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease ("CVD"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of the WELL AI Decision Support ("WAIDS") product offering. The co-pilot will be deployed into WELL Diagnostic Centres, Canada's largest cardiology and medical... Read More

HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of liabilities in Q2-2024. HEALWELL has successfully settled certain payment obligations related to the legacy MCI Medical Clinics Inc. ("MCI Ontario") business, resulting in extinguishing $3.9 million in future liabilities including rent and operating costs, and $2.5 million of payments in arrears. In... Read More

HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL's proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL's profitability. Serving five different provincial health clients across Canada, VeroSource is an end-to-end, customizable, cloud-based data interoperability platform that... Read More

HEALWELL completes USD $2,000,000 strategic investment into an xAI investment vehicle as part of its capital allocation strategy where it seeks to enhance and accelerate the development of its healthcare focused data science capabilities by partnering with world class platforms and seeking opportunities to integrate them with its own proprietary data and technology. HEALWELL has made this investment through Think 1 st... Read More

Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL " or the " Company "), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the voting results from its annual general meeting of the shareholders of the Company held on June 25, 2024 (the " Meeting "). Shareholders holding shares entitled to exercise... Read More

Pentavere collaborated with Princess Margaret Cancer Centre's Radiation Oncology Department to assess the feasibility and accuracy of DARWEN™ AI to find patients experiencing radiation related toxicities based on information retrieved from electronic health records. The data and results from this groundbreaking AI research collaboration have been accepted for presentation at the American Society for Radiation Oncology in... Read More

HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service Contract Research Organizations ("CRO") headquartered in Canada. BioPharma is focused on bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed to date with approximately 250 pharma clients since inception. BioPharma is expected to generate between $35 to $40 Million of revenue in 2024... Read More

HEALWELL enters into an agreement to acquire VeroSource Solutions Inc. and its end-to-end, customizable, cloud-based platform that enables patients, care providers and administrators to seamlessly access and interact with healthcare data. VeroSource currently serves five provincial health clients and is expected to generate over $8 million in revenues in 2024 with an expected EBITDA 1 margin of over 10%. Historically,... Read More

Pentavere’s partnership with Takeda to pioneer real-world evidence analysis for HAE patients, addressing critical gaps in treatment understanding. This innovative research collaboration has generated one of the largest cohort data sets globally of HAE with normal C1 inhibitor and will be utilized in enhancing patient outcomes through better understanding of current treatment use and clinical outcomes. This partnership and... Read More

Experienced finance and technology executive Anthony Lam joins as the Company’s new Chief Financial Officer. Mr. Lam will replace Mr. Scott Nirenberski who has been CFO since Sept 2020. TORONTO, June 04, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the appointment of Anthony Lam as... Read More

TORONTO, May 22, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) is pleased to announce today that it has closed its previously announced “bought deal” private placement offering and issued 14,815,000 units of the Company (the “ Units ”) at a price of $1.35 per Unit, for aggregate gross proceeds of $20,000,250 (the “ Offering ”). Dr. Alexander Dobranowski, CEO of HEALWELL commented, “... Read More

Pentavere partnered with Sunnybrook Health Sciences Centre to demonstrate how Pentavere’s DARWEN™ AI platform can help enhance cancer staging to improve patient outcomes. Results of this collaboration were presented at the prestigious American Head and Neck Society annual conference and published in JAMA Otolaryngology , which is the highest impact journal for Otolaryngologic or ‘head and neck’ cancers. This is the first... Read More

HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD. HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published... Read More

HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023. Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue run rate has more than doubled to over $20 million with the... Read More

HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, May 14, 2024, at 5:00 pm EDT (2:00 pm PDT). TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (" HEALWELL " or the " Company ") (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2024 financial results for the period ended March 31,... Read More

TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“ Clarus ”) and Eight Capital Corp. (“ Eight ”), as Co-Bookrunners and Co-Lead Underwriters (the “ Co-Lead Underwriters ”), on behalf of a syndicate of underwriters (collectively, the “ Underwriters ”), to increase the size... Read More

TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (" HEALWELL " or the " Company ") (TSX: AIDX), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an agreement pursuant to which Clarus Securities Inc. and Eight Capital, as lead underwriters and co-bookrunners, together with a syndicate of underwriters (collectively, the “ Underwriters ”), will purchase... Read More

Khure Health will be presenting at the National Kidney Foundation Spring Clinical Meetings on May 14-18, 2024 in Long Beach, CA. Pentavere will be presenting at the following medical conferences: Canadian Retina Society Annual Meeting on May 3-5, 2024 in Montreal, QC. American Head & Neck Society Annual Meeting on May 15-16, 2024 in Chicago, IL. American Medical Informatics Association (AMIA) Clinical Informatics Conference... Read More

Pentavere has published industry’s first peer-reviewed paper utilizing AI and large language models (or LLMs) to identify rare lung cancer patients. Industry applications may include Real World Evidence generation, identification of areas of unmet clinical need and optimization of cancer therapy and care pathways. Pentavere is an AI-powered patient identification company and this validated instance of identifying cancer... Read More

LD Micro Invitational XIV on April 8-9, 2024, in New York City, NY Bloom Burton & Co. Healthcare Investor Conference on April 16-17, 2024, in Toronto, ON Planet MicroCap Showcase: VEGAS 2024 on April 30 to May 2, 2024, in Las Vegas, NV TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) (OTCQX: HWAIF), a healthcare technology company focused on AI and data science for... Read More

HEALWELL AI achieved annual revenue from continuing operations of $7.32 million in fiscal 2023. HEALWELL ended 2023 with a strong balance sheet, having secured approximately $29.5 million from convertible debt and equity financings. Since its relaunch in Q4 2023, the Company’s annual revenue run rate has more than doubled to over $20M with the largest component of revenues now coming from SaaS and services. Management... Read More

HEALWELL AI to hold a conference call and simultaneous webcast on Thursday, March 28, 2024, at 1:00 pm EST (10:00 am PST). TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2023 financial results for the... Read More

Intrahealth is pleased to report on a recent customer implementation with Toronto Public Health, a health unit responsible for delivering public health programs and services, enforcing public health regulations, and reporting to the Toronto Board of Health on public health issues. Intrahealth now serves more public health units across Ontario than any other provider of Electronic Health Records (EHR) software. Intrahealth... Read More

HEALWELL debuted in the fourth quarter of 2023 and since then has achieved significant milestones including raising approximately $29.5 million, completing the acquisition of a majority interest in AI healthcare company Pentavere, announcing that it is powering WELL AI Decision Support, the first AI-powered physician co-pilot product adopted by WELL Health Technologies (TSX: WELL), and announcing the acquisition of... Read More

HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S. healthcare providers with a suite of artificial intelligence (AI) powered preventative care solutions. HEALWELL’s Pentavere Research Group Inc. has partnered with WELL Health USA’s CRH Medical to access U.S. clinical data to gain insights in... Read More

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) (OTCQX: HWAIF), a data science and AI company focused on preventative care, is pleased to announce that it has filed a final short form base shelf prospectus (the “ Shelf Prospectus ”) with the securities commissions in each of the provinces of Canada. The Shelf Prospectus will allow the Company to undertake offerings of... Read More

Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care. Mr. Shahbazi’s appointment is strategically important for shareholders of both WELL and HEALWELL given the shared objective between the companies to create the most advanced and easy to use AI inspired tools that can equip care providers with various ‘Co-Pilots’... Read More

Intrahealth is pleased to report on a recent enterprise customer installation at the Canuck Place Children’s Hospice in Vancouver, BC. Intrahealth’s Profile EHR will serve as the underlying digital infrastructure to streamline program delivery and improve the experience for both Canuck Place children and their families. This customer implementation reflects Intrahealth’s expanding footprint and a growing opportunity for the... Read More

Pentavere continues to publish ground-breaking AI work accepted at prestigious global medical conferences and leading oncology organizations. In the past quarter Pentavere presented its AI work, in partnership with leading academic centers and global pharmaceutical companies at a number of prestigious conferences. In a recent report focused on AI in Health ( 1) , The Organization for Economic Cooperation and Development... Read More

HEALWELL has completed the previously announced acquisition of Intrahealth, a SaaS based enterprise class multi-national EHR (Electronic Health Record) provider supporting approximately 15,000 clinicians providing care for millions of patients from small clinics to large health delivery organizations in its global network across Canada, Australia and New Zealand. Intrahealth is expected to generate over $12 million in... Read More